DE68909947T2 - Pentacyclische triterpenoid-verbindungen als topoisomerase-inhibitoren oder zell-differenzierungs-induktoren. - Google Patents

Pentacyclische triterpenoid-verbindungen als topoisomerase-inhibitoren oder zell-differenzierungs-induktoren.

Info

Publication number
DE68909947T2
DE68909947T2 DE89910793T DE68909947T DE68909947T2 DE 68909947 T2 DE68909947 T2 DE 68909947T2 DE 89910793 T DE89910793 T DE 89910793T DE 68909947 T DE68909947 T DE 68909947T DE 68909947 T2 DE68909947 T2 DE 68909947T2
Authority
DE
Germany
Prior art keywords
mono
alkyl
cancer
alkenyl
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89910793T
Other languages
German (de)
English (en)
Other versions
DE68909947D1 (de
Inventor
C Cook
Qi-Cheng Institute Of Mat Fang
Yue-Wei Research Triangle Lee
De-Hua Chang Baishan Instit Li
Zhen-Guo Chang Baishan In Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RES TRIANGLE INST RESEARCH TRI
RTI International
Original Assignee
RES TRIANGLE INST RESEARCH TRI
RTI International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RES TRIANGLE INST RESEARCH TRI, RTI International filed Critical RES TRIANGLE INST RESEARCH TRI
Publication of DE68909947D1 publication Critical patent/DE68909947D1/de
Application granted granted Critical
Publication of DE68909947T2 publication Critical patent/DE68909947T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02—Saturated compounds containing hydroxy or O-metal groups
    • C07C62/06—Saturated compounds containing hydroxy or O-metal groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE89910793T 1988-08-24 1989-08-24 Pentacyclische triterpenoid-verbindungen als topoisomerase-inhibitoren oder zell-differenzierungs-induktoren. Expired - Fee Related DE68909947T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23590388A 1988-08-24 1988-08-24

Publications (2)

Publication Number Publication Date
DE68909947D1 DE68909947D1 (de) 1993-11-18
DE68909947T2 true DE68909947T2 (de) 1994-02-24

Family

ID=22887334

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89910793T Expired - Fee Related DE68909947T2 (de) 1988-08-24 1989-08-24 Pentacyclische triterpenoid-verbindungen als topoisomerase-inhibitoren oder zell-differenzierungs-induktoren.

Country Status (10)

Country Link
EP (1) EP0431076B1 (cg-RX-API-DMAC10.html)
JP (1) JP2828295B2 (cg-RX-API-DMAC10.html)
KR (1) KR100187738B1 (cg-RX-API-DMAC10.html)
CN (1) CN1041204C (cg-RX-API-DMAC10.html)
AU (1) AU630374B2 (cg-RX-API-DMAC10.html)
CA (1) CA1330944C (cg-RX-API-DMAC10.html)
DE (1) DE68909947T2 (cg-RX-API-DMAC10.html)
DK (1) DK31391A (cg-RX-API-DMAC10.html)
TW (1) TW225990B (cg-RX-API-DMAC10.html)
WO (1) WO1990001937A1 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201903B4 (de) * 1992-01-24 2004-04-15 Hermann P.T. Prof. Dr.Med. Ammon Pharmazeutische Verwendung von Boswelliasäuren
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
DE4445728A1 (de) * 1994-12-21 1996-06-27 Simmet Th Prof Dr Verwendung von Boswelliasäure zur Behandlung von Hirntumoren
DE19531067A1 (de) † 1995-08-23 1997-02-27 Hermann P T Prof Dr Med Ammon Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität
EP1173162A1 (en) * 1999-04-30 2002-01-23 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
WO2002085921A2 (de) * 2001-03-01 2002-10-31 Johann Jauch Einfaches verfahren zur synthese von boswelliasäuren und derivaten davon
CN1304007C (zh) * 2002-02-04 2007-03-14 中国医学科学院药物研究所 乙酰乳香酸在制备肿瘤转移抑制剂中的应用
US8028292B2 (en) 2004-02-20 2011-09-27 Sony Computer Entertainment Inc. Processor task migration over a network in a multi-processor system
MX2009013758A (es) * 2007-06-25 2010-03-04 Plant Bioscience Ltd Enzimas que actuan en la sintesis del triterpeno.
DE102008015607A1 (de) * 2008-03-26 2009-10-15 Universität Tübingen Verwendung von Boswelliasäuren und synthetischen Boswelliasäurederivaten zur Hemmung der mikrosomalen Prostaglandin E2 Synthase und des Cathepsin G
EP2408461B1 (de) 2009-03-17 2016-01-27 Ertelt, Herta Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501734A (en) * 1981-03-06 1985-02-26 Wakunaga Yakuhin Kabushiki Kaisha Promotion of absorption of drugs administered through the alimentary system

Also Published As

Publication number Publication date
AU630374B2 (en) 1992-10-29
AU4303389A (en) 1990-03-23
JP2828295B2 (ja) 1998-11-25
DE68909947D1 (de) 1993-11-18
DK31391D0 (da) 1991-02-22
TW225990B (cg-RX-API-DMAC10.html) 1994-07-01
EP0431076A1 (en) 1991-06-12
JPH04500209A (ja) 1992-01-16
KR900701280A (ko) 1990-12-01
EP0431076A4 (en) 1992-01-15
WO1990001937A1 (en) 1990-03-08
CN1043131A (zh) 1990-06-20
KR100187738B1 (ko) 1999-06-01
EP0431076B1 (en) 1993-10-13
DK31391A (da) 1991-02-22
CA1330944C (en) 1994-07-26
CN1041204C (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
US5064823A (en) Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
EP1299406B1 (de) Curcumin-derivate mit gegenüber curcumin verbesserter wasserlöslichkeit und diese enthaltende arzneimittel
DE69815527T2 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
JP2694479B2 (ja) カプサイシン様応答のための活性の可変スペクトルを有する化合物の新規種類、それらの組成物および用途
DE69618600T2 (de) Colchicine derivate, deren verwendung und sie enthaltende formulierungen
DE69525736T2 (de) Oligonukleotid und kanzerostatisches mittel das dieses als aktiven inhaltstoff enthält
WO2009117987A2 (de) Verwendung von boswelliasäuren und synthetischen boswelliasäurederivaten zur hemmung der mikrosomalen prostaglandin e2 synthase und des cathepsin g
Marshall et al. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine
DE60206531T2 (de) Ein kräutermolekül als potentielles anti-leukämisches arzneimittel
EP0501205B1 (de) Antiphlogistisches Mittel
DE68927610T2 (de) Antikörper-Arzneimittel Konjugale
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
EP2753630A1 (de) 4-methylcatecholderivate und deren verwendung
JP2828295B2 (ja) トポイソメラーゼ阻害剤または細胞分化誘導剤としての五環式トリテルペノイド化合物
DE69533267T2 (de) Colchicin-derivate sowie ihre therapeutische Verwendung
DE60017133T2 (de) Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
DE60316389T2 (de) Verwendung von Hederagenin-3-O-a-L-rhamnopyranosyl((1->2)-(ß-D-glucopyranosyl (1->4))-a-L-arabinopyranosid oder eines dieses enthaltenden Extrakts aus Pulsatillae radix als ein therapeutisches Mittel für solide Tumore
DE2831579C3 (de) Tetrahydropyranylether von Daunomycin und Adriamycin, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE69218222T2 (de) Neue ganglioside-derivaten
DE4201942A1 (de) Phenonverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
EP0300960B1 (de) Neue pharmazeutische Präparate sowie neue Lactosylverbindungen und ihre Herstellung
EP1448179B1 (de) Substituierte bicyclo 3.3.1 nonan-2,4,9-trione als pharmazeutische wirkstoffe
CN1651395B (zh) 冰片脂肪酸酯衍生物及含有该衍生物的制剂
WO2007073583A1 (en) A method of treatment and agents useful for same
DE2265235A1 (de) Heilmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee